NOT-HG-22-016: Notice of Early Termination of NOT-HG-22-006, Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)

Notice of Early Termination of NOT-HG-22-006, “Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)

Notice Number:

NOT-HG-22-016

Key Dates

Release Date:

April 7, 2022

Related Announcements

NOT-HG-22-006 - Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)

PAR-20-153 - NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

Effective immediately, the Funding Opportunity Announcement (FOA) NOT-HG-22-006 – “Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed)” will be terminated.

NOT-HG-22-006 will be replaced immediately with NOT-HG-22-017.

Inquiries

Please direct all inquiries to:

Bettie J. Graham, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-496-7531
E-Mail: [email protected]